SSS26

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameSSS26

Drug Alias NameSSS26SSS-26

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator Companies3sbio Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies3sbio Inc

Active IndicationsN/A

Inactive IndicationsMetabolic Diseases

ATC CodeN/A